AUTHORS
Shannon Phillips, PhD, RN, Alyssa Schlenz, PhD2, Ofelia A. Alvarez, MD3, Najibah Galadanci, PhD, MBBS, MPH4, Jeffrey Lebensburger, DO5, Christina Abrams, MD6, Chelsea Rivenbark7, Julie Kanter, MD8
AFFILIATIONS
1 Medical University of South Carolina, Charleston, South Carolina, United States
2 University of Colorado Anschutz School of Medicine, Aurora, Colorado, United States
3 University of Miami, Miami, Florida, United States
4 University of Alabama at Birmingham, Birmingham, Alabama, United States
5 University of Alabama at Birmingham, Birmingham, Alabama, United States
6 Medical University of South Carolina, Charleston, South Carolina, United States
7 East Carolina University, Greensville, North Carolina, United States
8 University of Alabama at Birmingham, Birmingham, Alabama, United States
ABSTRACT
Background: Depression and suicidal ideation (SI) are understudied among adolescents and young adults (AYA) with sickle cell disease (SCD). In the general population, there is a marked increase in the onset of depression during adolescence with a national prevalence rate of 14.5-26.5%. AYAs with SCD navigate major developmental and healthcare transitions, and depression has been associated with several negative SCD health outcomes (e.g., worse pain and functioning, higher healthcare utilization and mortality risk). Prompt identification of depressive symptoms and modifiable targets for intervention are therefore critical. The Self-Management for Youth Living with Sickle Cell Disease (SMYLS, R01 NR02060) multisite study is designed to improve AYA outcomes by enhancing self-management behaviors. This SMYLS sub-analysis evaluated the prevalence of positive depression screening and SI in AYAs with SCD and examined overall depressive symptoms in relation to health-related quality of life (HRQL) domains to determine aspects of HRQL relevant for potential support and interventions in routine SCD care.
Methods: We abstracted baseline measures between 4/2024 and 6/2026 from 172 AYA (98 adolescents: 14-17 years; 74 young adults, YA: 18-21 years) who were enrolled in SMYLS across 4 sites in the Southeastern US. All measures were completed remotely; however, those who endorsed depression or SI were contacted for emergent support. HRQL was assessed via the PedsQL Generic Core Scales Version 4.0 and the SCD Module Version 3.0, and depression screening via the Pediatric Health Questionnaire (A/9). Higher scores on the PedsQL measures indicate better HRQL, while higher scores on the PHQ-A/9 indicate greater depressive symptom severity. For the PHQ-A/9, positive depression screenings (total score > or = 10) and SI were examined to describe overall prevalence. Pearson correlation coefficients between the PHQ-A/9 total score and HRQL domains were assessed to identify the HRQL domains most strongly linked to depressive symptoms. Adolescents and YA were analyzed separately, given potential developmental and measurement differences between groups.
Results: Enrolled participants had an average age of 17 years (SD = 2.3). Fifty-nine percent of AYAs identified as female, 41% as male, and <1% as non-binary. Ninety-seven percent identified as Black/African American, 37% identified Hispanic/Latino/a, and 2% as other/mixed. Sixty-two percent had HbSS, 32% had HbSC, 3% had HbS-beta plus thalassemia, 2% had HbS-beta zero thalassemia, and <1% had HbSD. Prevalence of positive depression screenings was 19% (20% of adolescents; 19% of YA). Prevalence of SI was 9% (10% of adolescents; 7% of young adults). Among adolescents, higher scores on depression screening were correlated with lower scores on HRQL domains assessing emotional, social, school, and communication outside of the health care system (r = -.43 to -.62; medium-large to large). Associations were weaker, though still present, in domains assessing physical functioning, pain, treatment, and communication with the healthcare system (-.22 to -.35; small to medium). In contrast, for YA, greater depressive symptoms were strongly correlated with worse scores in nearly every HRQL domain (-.47 to -.77; medium-large to large), except for pain management and control (-.33).
Conclusion: AYAs with SCD endorsed high rates of depression on screening (~1/5) as well as notable rates of SI (~1/10). While reports of suicide in this population are very limited, they reflect the critical importance of screening AYA for SI in addition to depression and HRQL screening. Importantly, SCD centers should adopt assessments in the context of a follow-up interview with a trained provider for elevated depression screening and a plan in place for SI. Further, among adolescents, depression was more strongly associated with psychosocial and communication aspects of HRQL, and a range of factors were strongly associated with depression for YA. These findings suggest that domain-level analysis of HRQL may be more helpful for adolescents with depression relative to YA. Further analysis and interviews should be completed to determine underlying etiology of these relationships; however, possible explanations include 1) age-related changes in disease processes; 2) YA with depression broadly responding more negatively to HRQL measures due to greater distress; and 3) differences in measurement properties for HRQL for adolescents and YA.
DISCLOSURES
Shannon Phillips, PhD, RN: Quilt Health - Consultancy (Includes expert testimony)